These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16465854)

  • 21. Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.
    Hall HA; Zimmermann B
    Arthritis Rheum; 2006 Dec; 55(6):982-4. PubMed ID: 17139649
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
    Rajakulendran S; Deighton C
    Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
    [No Abstract]   [Full Text] [Related]  

  • 23. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe interstitial pneumonitis associated with infliximab therapy.
    Chatterjee S
    Scand J Rheumatol; 2004; 33(4):276-7. PubMed ID: 15370726
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
    J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-alpha antagonists: pulmonary legionellosis.
    Prescrire Int; 2007 Feb; 16(87):20. PubMed ID: 17326282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of pseudogout during etanercept treatment.
    Josefina M; Ana CJ; Ariel V; Silvio AA
    J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
    Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.
    Lindsay K; Melsom R; Jacob BK; Mestry N
    Rheumatology (Oxford); 2006 Aug; 45(8):1048-9. PubMed ID: 16760195
    [No Abstract]   [Full Text] [Related]  

  • 30. Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept.
    Rachapalli S; O'Daunt S
    Arthritis Rheum; 2005 Mar; 52(3):987. PubMed ID: 15751076
    [No Abstract]   [Full Text] [Related]  

  • 31. Can tumor necrosis factor alpha blockade predispose to severe babesiosis?
    Taiwo B; Lee C; Venkat D; Tambar S; Sutton SH
    Arthritis Rheum; 2007 Feb; 57(1):179-81. PubMed ID: 17266091
    [No Abstract]   [Full Text] [Related]  

  • 32. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
    Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical infection with Strongyloides sterocoralis following etanercept use for rheumatoid arthritis.
    Boatright MD; Wang BW
    Arthritis Rheum; 2005 Apr; 52(4):1336-7. PubMed ID: 15818680
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab.
    Schoe A; van der Laan-Baalbergen NE; Huizinga TW; Breedveld FC; van Laar JM
    Arthritis Rheum; 2006 Feb; 55(1):157-9. PubMed ID: 16463430
    [No Abstract]   [Full Text] [Related]  

  • 35. Giant cell arteritis in a patient taking etanercept and methotrexate.
    Seton M
    J Rheumatol; 2004 Jul; 31(7):1467. PubMed ID: 15229983
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).
    Jacobelli S; André M; Alexandra JF; Dodé C; Papo T
    Rheumatology (Oxford); 2007 Jul; 46(7):1211-2. PubMed ID: 16935919
    [No Abstract]   [Full Text] [Related]  

  • 37. Adalimumab-induced bronchospasm: not a class effect.
    Janssen R; Krivokuca I; Kruize AA; Koenderman L; Lammers JW
    Thorax; 2008 May; 63(5):472-3. PubMed ID: 18443165
    [No Abstract]   [Full Text] [Related]  

  • 38. Etanercept-associated SLE with lupus nephritis.
    Neradová A; Stam F; van den Berg JG; Bax WA
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract]   [Full Text] [Related]  

  • 39. Macrophage activation syndrome after etanercept treatment.
    Sandhu C; Chesney A; Piliotis E; Buckstein R; Koren S
    J Rheumatol; 2007 Jan; 34(1):241-2. PubMed ID: 17216706
    [No Abstract]   [Full Text] [Related]  

  • 40. Phlegmonous abscess associated with etanercept therapy.
    D'Amore M; Minenna G; Favoino E; D'Amore S
    Panminerva Med; 2006 Sep; 48(3):199-200. PubMed ID: 17122757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.